NEW YORK (TheStreet) -- RATINGS CHANGES

Abbvie (ABBV - Get Report) upgraded at Citi: ABBV was upgraded to neutral, Citigroup said. Valuation call, based on a $60 price target.

Boston Scientific (BSX - Get Report) upgraded at Needham: BSX was upgraded from hold to buy, Needham said. $21 price target. Strong product cycle should drive accelerating growth.  

Citigroup (C - Get Report) upgraded at Jefferies: Rating on C was raised from hold to buy, Jefferies said. Valuation call, based on a $60 price target. 

Citigroup (C - Get Report) upgraded at Credit Suisse: Rating on C was boosted to outperform from neutral, Credit Suisse said. Valuation call, based on a $62 price target. 

DSW (DSW) downgraded at B. Riley: DSW was downgraded from buy to neutral, B. Riley said. $31 price target. Company may have to discount more to maintain sales growth.  

JC Penney (JCP - Get Report) upgraded at Sterne Agee: JCP was upgraded from neutral to buy, Sterne Agee said. $13 price target. Visit with new CEO adds to confidence about the turnaround potential. Buy rating. 

Newell Rubbermaid (NWL - Get Report) rated new buy at Jefferies: NWL was initiated with a buy rating, Jefferies said. Company also placed on the Franchise Picks list. $50 price target. Company is seeing accelerating organic sales growth. 

New York Times (NYT - Get Report)  was downgraded to hold by TheStreet Ratings. You can view the full analysis from the report here: NYT.

Ocean Shore Holding  (OSHC) was upgraded to buy at TheStreet Ratings. You can view the full analysis from the report here: OSHC

Qorvo (QRVO - Get Report) downgraded at Keybanc: QRVO was downgraded from overweight to sector weight, Keybanc said. More cautious on the company, following checks in Asia. 
  
Transocean
(RIG - Get Report) upgraded at Deutsche: RIG was upgraded from sell to hold, Deutsche Bank said. $10 price target. Industry is on the cusp of a major restructuring.

Varian Medical (VAR - Get Report) downgraded at Goldman. VAR was downgraded from neutral to sell, Goldman Sachs said. $76 price target. Organic growth will face pressure in the coming quarters. 


Stock Comments / EPS Changes

BlackBerry (BBRY) estimates, target cut at Goldman: Shares of BBRY now seen reaching $7, according to Goldman Sachs. Estimates also reduced, as key metrics continue to fall short of expectations. Sell rating. 

Caterpillar (CAT - Get Report) estimates, target cut at Jefferies: Shares of CAT now seen reaching $63, according to Jefferies. Estimates also reduced, given the company's new guidance. Hold rating. 

Expedia (EXPE - Get Report) estimates, target raised at JMP: Shares of EXPE now seen reaching $151, according to JMP Securities. Estimates also increased, given the Orbitz acquisition. Outperform rating. 

Mattel (MAT - Get Report) estimates, target reduced at Oppenheimer: Shares of MAT now seen reaching $27, according to Oppenheimer. Estimates also cut, given the stronger dollar. Outperform rating. 

Strategy Calls / Market Calls

S&P 500 (SPY - Get Report) estimates, target cut at RBC: S&P 500 estimates were reduced through 2016, RBC Capital said. Oil and slower global growth will weigh on profits. 2015 target also lowered to 2,100.

This article was written by a staff member of TheStreet.